Article
The Role of Somatic Mutations on the Immune Response of the Tumor Microenvironment in Prostate Cancer.
International journal of molecular sciences - 2 Sept 2021
Melo Camila Morais, Vidotto Thiago, Chaves Luiz Paulo, Lautert-Dutra William, Reis Rodolfo Borges Dos, Squire Jeremy Andrew
Abstract excerpt
Immunotherapy has improved patient survival in many types of cancer, but for prostate cancer, initial results with immunotherapy have been disappointing. Prostate cancer is considered an immunologically excluded or cold tumor, unable to generate an effective T-cell response against cancer cells. However, a small but significant percentage of patients do respond to immunotherapy, suggesting that some specific...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
